Vascular Pharmaceuticals, Inc. Completes $16 Million Equity Financing, Signs Agreement with Janssen Biotech, Inc.

Vascular Pharma has raised a $16 million Series A round of financing, led by Intersouth Partners. The company has also signed an agreement with Janssen Biotech that is a structured buyout option at the end of Phase 2 studies of Vascular's drug.... [more]

View complete Press Release article